SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB: NVLX) reported today significant interest was generated in its unique cell encapsulation technology, as well as its existing products, at BIO Convention 2011, the world's largest biotech convention held last week in Washington, D.C. This was the first public appearance of SG Austria and Nuvilex together since the acquisition that added a Cell and Molecular Biology Division to Nuvilex and subsequently placed Nuvilex directly into the biotechnology arena. As a result of SG Austria’s prior design to be participants at the Singapore Pavilion in the Convention, both the Nuvilex President and CEO, Dr. Robert Ryan, and COO, Dr. Gerald Crabtree, joined the SG Austria Executive Director, Dr. Walter Gunzburg, and COO, Dr. John Dangerfield, who had both flown in from Singapore for the convention.
